Pharmacist-Assisted Titration of Rx to Implement Optimal Medical Therapy for Heart Failure
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorVA Office of Research and Development
About this trial
Many Veterans who are hospitalized with heart failure do not receive all the recommended heart medications at the right doses before they leave the hospital or in the weeks following discharge. This study tests whether a team of clinical pharmacists and cardiologists, working virtually, can improve heart failure medication prescribing for Veterans at VA medical centers. The pharmacist and cardiologist team reviews patient records and provides recommendations to the treating doctors and primary care providers caring for Veterans with heart failure. The goal is to increase use of guideline-recommended medications, which have been shown to improve survival, reduce hospitalizations, and improve quality of life.
Eligibility criteria
Qualifiers
Admission to a VA medical center or VA-paid community hospital within the preceding 3 months with a primary diagnosis of heart failure
The primary study cohort will consist of those admitted to a VA medical center, while the secondary study cohort will consist of patients admitted to VA-paid community hospitals
Left ventricular ejection fraction ≤ 40%
Not on optimal guideline-directed heart failure medication classes or doses, as assessed in the electronic health record
Disqualifiers
Hemodynamic instability
Receiving comfort care measures alone or enrolled in hospice
Trial design
Treatments tested in this trial
- Pharmacist/Cardiologist Virtual Team Digital Consultation
Treatment groups
585 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov